Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed ...

AstraZeneca’s biologics division MedImmune is to spin out a new standalone biotech to develop six early-stage inflammation and autoimmunity programmes. To be known as Viela Bio, the spin-out ...

AstraZeneca and its biologics research arm MedImmune have signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease. The ...

MedImmune Inc. Profit and Loss IND: Others | ISIN code: | SECT: General The P&L A/C page of MedImmune Inc. presents the key P&L A/c Ratios, its comparison with the sector peers and 5 years of Profit & ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

The latest international news, investigations and analysis from Africa, the Americas, Asia, Australia, Canada, Europe, the Middle East and the U.K.

The artificial intelligence application has led to $9.3 million in claims paid that might have been denied. What's more, the tech has resulted in $871,000 in new revenue for Medicare Severity ...

Today's Duluth news and coverage from Duluth, BWCA, Grand Marais, North Shore and the Iron Range from the Minnesota Star Tribune.

Genes and Genetics News. Read today's medical research in genetics including what can damage genes, what can protect them, and more.

Get the latest health news, diet & fitness information, medical research, health care trends and health issues that affect you and your family on ABCNews.com ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

The latest news on cancer, health, medicines, cancer treatments, cancer research, cancer studies and types of cancer.